Now Reading: Cipla to invest Rs 200 crore in Bommasandra plant expansion
-
01
Cipla to invest Rs 200 crore in Bommasandra plant expansion
The Karnataka government has said pharmaceutical company Cipla will invest Rs 200 crore to expand its manufacturing facility at Bommasandra in Bengaluru, Deccan Herald reported. Rocket India, a plant-based protein manufacturer, is…
The Karnataka government has said pharmaceutical company Cipla will invest Rs 200 crore to expand its manufacturing facility at Bommasandra in Bengaluru, Deccan Herald reported. Rocket India, a plant-based protein manufacturer, is expected to invest a further Rs 100 crore expanding its facility at Gokak in Belagavi district. Both figures emerged from meetings the state held in Mumbai, where an industries delegation led by minister MB Patil met representatives of several companies, among them Blackstone, Saint-Gobain, Horizon, Henkel, KEC International and ideaForge Technology. Beyond the rupee figures and locations, the report gives no project timeline, no employment estimate, no financing detail and no word on regulatory clearances.
Indian Opinion Analysis
Both figures are stated intentions announced after the Mumbai meetings rather than work already under way, and with no timeline, hiring figure or clearance detail attached, neither project can be read here as more than that. The Rs 200 crore Cipla figure and the Rs 100 crore Rocket India figure both came from the same round of Mumbai meetings, alongside talks with several other companies, so both should be read on the same footing until either firm reports next steps. Work at the Bommasandra and Gokak sites, or a figure from Cipla or Rocket India on either expansion, is what would move these announcements onto a record of their own.
Source: www.deccanherald.com
This brief was synthesised by AI from the source linked above.
